Pankti Reid

15PUBLICATIONS
35CO-AUTHORS
AutoimmunityBusiness analyticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Toxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|May 28, 2026
Comparing immune-checkpoint inhibitor-mediated inflammatory arthritis to polymyalgia rheumatica: a prospective cohort study.

|Jul 04, 2025
Real-World Analysis of Patient Characteristics, Adverse Events, and Economic Burden Among Patients with Giant Cell Arteritis Treated with Glucocorticoids.

Jeffrey R Curtis, Denise T Kruzikas, Ana Romero

|May 25, 2024
Studying Outcomes after Steroid-Sparing Immunosuppressive Agent vs. Steroid-Only Treatment for Immune-Related Adverse Events in Non-Small-Cell Lung Cancer (NSCLC) and Melanoma: A Retrospective Case-Control Study.

Sharjeel Syed, Jacobi Hines, Rachel Baccile

|Feb 24, 2024
Immune Checkpoint Inhibitors and Lupus Erythematosus.

Hans Vitzthum von Eckstaedt, Arohi Singh, Pankti Reid

|Dec 21, 2023
Safety and effectiveness of combination versus monotherapy with immune checkpoint inhibitors in patients with preexisting autoimmune diseases.

Pankti Reid, Sabina Sandigursky, Juhee Song

|Aug 19, 2023
JAK inhibitors and black box warnings: what is the future for JAK inhibitors?

Kate Tokareva, Pankti Reid, Victor Yang

Pageof 3

Frequent Collaborators

3 joint publications

Sherin Rouhani

3 joint publications

David Liew

2 joint publications

Victor Yang

2 joint publications

Thomas F Gajewski